Stock ANAB ANAPTYSBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart AnaptysBio, Inc.

Equities

ANAB

US0327241065

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
26.23 USD +1.86% Intraday chart for AnaptysBio, Inc. -0.42% +22.46%
Apr. 16 Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target MT
Apr. 11 Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ANAPTYSBIO, INC. Stock AnaptysBio, Inc.
 703M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 108B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 23.46B -
BIONTECH SE Stock BioNTech SE
 21.72B -
GENMAB A/S Stock Genmab A/S
 18.64B
  1. Stock Market
  2. Equities
  3. ANAB Stock
  4. Charts AnaptysBio, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW